{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:03:09Z","timestamp":1786993389565,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jss.2024.07.060","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T15:37:24Z","timestamp":1725896244000},"page":"865-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preoperative Chemotherapy Does Not Impact Failure to Rescue in Patients Undergoing Pancreatectomy"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3192-8189","authenticated-orcid":false,"given":"Apar","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant","family":"Morocho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burt","family":"Cagir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6624-4735","authenticated-orcid":false,"given":"Rebekah","family":"Macfie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2024.07.060_bib1","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.3748\/wjg.v21.i11.3157","article-title":"Update on the management of pancreatic cancer: surgery is not enough","volume":"21","author":"Ansari","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jss.2024.07.060_bib2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jss.2024.07.060_bib3","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jss.2024.07.060_bib4","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2022.3829","article-title":"Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial","volume":"8","author":"Conroy","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib5","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1245\/s10434-014-3722-6","article-title":"The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma","volume":"21","author":"Wu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib6","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1245\/s10434-023-13533-0","article-title":"Major postoperative complications limit adjuvant therapy administration in patients undergoing pancreatoduodenectomy for distal cholangiocarcinoma or pancreatic ductal adenocarcinoma","volume":"30","author":"Macfie","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/SLA.0000000000000378","article-title":"Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer","volume":"260","author":"Merkow","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2024.07.060_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fonc.2020.00245","article-title":"Neoadjuvant treatment in pancreatic cancer","volume":"10","author":"Oba","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.critrevonc.2007.08.002","article-title":"Neoadjuvant treatment for pancreatic cancer-A review","volume":"65","author":"Tse","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jss.2024.07.060_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12893-017-0291-1","article-title":"Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial","volume":"17","author":"Labori","year":"2017","journal-title":"BMC Surg"},{"key":"10.1016\/j.jss.2024.07.060_bib11","first-page":"418","article-title":"Neoadjuvant therapy for localized pancreatic cancer: guiding principles","volume":"6","author":"Fathi","year":"2015","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.2022.40.16_suppl.4134","article-title":"Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy: a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)","volume":"40","author":"Schwarz","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib13","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.TPS4204","article-title":"Alliance A021806: a phase III trial evaluating perioperative versus adjuvant therapy for resectable pancreatic cancer","volume":"41","author":"Chawla","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib14","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamaoncol.2020.7328","article-title":"Efficacy of perioperative chemotherapy for resectable pancreatic adenocarcinoma: a phase 2 randomized clinical trial","volume":"7","author":"Sohal","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamaoncol.2018.0329","article-title":"Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial","volume":"4","author":"Murphy","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00066-014-0737-7","article-title":"Neoadjuvant chemoradiation therapy with gemcitabine\/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trial","volume":"191","author":"Golcher","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.jss.2024.07.060_bib18","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2024.07.060_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/SLA.0b013e3181823485","article-title":"Successful implementation of the department of veterans affairs\u2019 national surgical quality improvement program in the private sector: the patient safety in surgery study","volume":"248","author":"Khuri","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2024.07.060_bib24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","article-title":"The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after","volume":"161","author":"Bassi","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.jss.2024.07.060_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.sla.0000217673.04165.ea","article-title":"One thousand consecutive pancreaticoduodenectomies","volume":"244","author":"Cameron","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2024.07.060_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/SLA.0000000000004155","article-title":"Surgical outcome results from SWOG S1505: a randomized clinical trial of mFOLFIRINOX versus gemcitabine\/Nab-paclitaxel for perioperative treatment of resectable pancreatic ductal adenocarcinoma","volume":"272","author":"Ahmad","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2024.07.060_bib22","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.hpb.2020.03.007","article-title":"Neoadjuvant therapy for pancreatic cancer changes the composition of the pancreatic parenchyma","volume":"22","author":"Rykina-Tameeva","year":"2020","journal-title":"HPB"},{"key":"10.1016\/j.jss.2024.07.060_bib23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1245\/s10434-017-6281-9","article-title":"Neoadjuvant therapy versus upfront resection for pancreatic cancer: the actual spectrum and clinical burden of postoperative complications","volume":"25","author":"Marchegiani","year":"2018","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480424004438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480424004438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:09:15Z","timestamp":1737562155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480424004438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":24,"alternative-id":["S0022480424004438"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2024.07.060","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Chemotherapy Does Not Impact Failure to Rescue in Patients Undergoing Pancreatectomy","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2024.07.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}